Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Meredith S Irwin Arlene Naranjo Fan F Zhang Susan L Cohn Wendy B London Julie M Gastier-FosterNilsa C RamirezRuthann PfauShalini ReshmiElizabeth WagnerJed NuchternShahab AsgharzadehHiroyuki ShimadaJohn M Maris Rochelle Bagatell Julie R Park Michael D Hogarty

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)

A revised 2021 COG neuroblastoma risk classifier (version 2) that uses the INRGSS and incorporates SCAs has been adopted to prospectively define COG clinical trial eligibility and treatment assignment.

Keyphrases

clinical trial
young adults
palliative care
randomized controlled trial
combination therapy
smoking cessation
replacement therapy